Article
Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain.
Journal of immunology (Baltimore, Md. : 1950) - 15 Nov 2005
Bill Jerome R, Mack Douglas G, Falta Michael T, Maier Lisa A, Sullivan Andrew K, Joslin Fenneke G, Martin Allison K, Freed Brian M, Kotzin Brian L, Fontenot Andrew P
Abstract excerpt
Chronic beryllium disease (CBD) is characterized by a CD4+ T cell alveolitis and granulomatous inflammation in the lung. Genetic susceptibility to this disease has been linked with HLA-DP alleles, particularly those possessing a glutamic acid at position 69 (Glu69) of the beta-chain. However, 15% of CBD patients do not possess a Glu69-containing HLA-DP allele, suggesting that other MHC class II alleles may be...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
